Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation
Authors:
Open Access
- 27 December 2022
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 41 (13) , 111897
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (01EO1503)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (315880/2021-0)
- Deutsche Forschungsgemeinschaft (KA 4035/1-1)
- Deutsche Forschungsgemeinschaft (CRC/TR 156)
- Deutsche Forschungsgemeinschaft (CRC1292)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/08216-2)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2016/10867-0)
This publication has 52 references indexed in Scilit:
- Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe PsoriasisJournal of Investigative Dermatology, 2012
- Supporting conditional mouse mutagenesis with a comprehensive cre characterization resourceNature Communications, 2012
- Act1, a novel U-box E3 ubiquitin ligase for IL-17R-mediated signallingCytokine, 2009
- Skin immune sentinels in health and diseaseNature Reviews Immunology, 2009
- Type I Interferon: Potential Therapeutic Target for Psoriasis?PLOS ONE, 2008
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growthNature, 2008
- Increased Expression of Wnt5a in Psoriatic PlaquesJournal of Investigative Dermatology, 2007
- Lentivirus-delivered stable gene silencing by RNAi in primary cellsRNA, 2003
- Keratins and the Keratinocyte Activation CycleJournal of Investigative Dermatology, 2001
- NF-κB: a key role in inflammatory diseasesJournal of Clinical Investigation, 2001